| |
| |
|
| Insider
Information: |
Henneman John B III |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
248,162 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,377,599 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
248,162 |
|
|
| Total
Value |
$3,377,599 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -27.9%
|
-31.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Integra Lifesciences Holdings Corp |
IART |
CorpVP, CAO |
2014-08-25 |
34,159 |
2003-07-14 |
0 |
Premium* |
|
|
Lumos Pharma Inc |
LUMO |
Chief Administrative O... |
2018-10-01 |
55,052 |
2014-10-01 |
0 |
Premium* |
|
|
Seaspine Holdings Corp |
SPNE |
Director |
2023-01-05 |
0 |
2016-06-07 |
0 |
Premium* |
|
|
R1 RCM Inc |
ACHI |
Director |
2022-06-21 |
0 |
2016-08-16 |
0 |
Premium* |
|
|
Aprea Therapeutics, Inc. |
APRE |
Director |
2024-03-13 |
8,139 |
2019-10-07 |
0 |
Premium* |
|
|
Anika Therapeutics Inc |
ANIK |
Director |
2023-06-14 |
29,936 |
2020-09-03 |
0 |
Premium* |
|
|
R1 Rcm Inc |
RCM |
Director |
2023-08-08 |
72,114 |
2022-06-21 |
0 |
Premium* |
|
|
Orthofix International N.V. |
OFIX |
Director |
2023-01-05 |
48,762 |
2023-01-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APRE |
Aprea Therapeutics, Inc. |
Director |
– • – |
2024-03-13 |
4 |
B |
$7.29 |
$50,009 |
D/D |
6,860 |
8,139 |
2.39 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
Director |
– • – |
2023-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
500 |
1,279 |
0 |
- |
|
| RCM |
R1 Rcm Inc |
Director |
– • – |
2023-08-08 |
4 |
S |
$17.17 |
$858,650 |
D/D |
(50,000) |
72,114 |
0 |
% |
|
| RCM |
R1 Rcm Inc |
Director |
– • – |
2023-08-08 |
4 |
OE |
$2.61 |
$130,500 |
D/D |
50,000 |
122,114 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Director |
– • – |
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
29,936 |
0 |
- |
|
| RCM |
R1 Rcm Inc |
Director |
– • – |
2023-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
11,324 |
72,114 |
0 |
- |
|
| OFIX |
Orthofix International N.... |
Director |
– • – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
14,052 |
48,460 |
0 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2023-01-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(82,654) |
0 |
0 |
- |
|
| OFIX |
Orthofix International N.... |
Director |
– • – |
2023-01-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
34,408 |
|
% |
|
| OFIX |
Orthofix International N.... |
Director |
– • – |
2023-01-05 |
4/A |
A |
$0.00 |
$0 |
D/D |
14,354 |
48,762 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
Director |
– • – |
2022-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
5,995 |
15,605 |
0 |
- |
|
| ACHI |
R1 RCM Inc |
Director |
– • – |
2022-06-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(54,751) |
0 |
0 |
- |
|
| RCM |
R1 Rcm Inc |
Director |
– • – |
2022-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
60,790 |
60,790 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Director |
– • – |
2022-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
7,954 |
23,436 |
0 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2022-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,943 |
82,654 |
0 |
- |
|
| ACHI |
R1 RCM Inc |
Director |
– • – |
2022-05-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,151 |
54,751 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
Director |
– • – |
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,610 |
9,610 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Director |
– • – |
2021-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
4,172 |
15,482 |
0 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,253 |
66,711 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Director |
– • – |
2021-05-18 |
4 |
B |
$42.86 |
$85,720 |
D/D |
2,000 |
11,310 |
2.39 |
% |
|
| ANIK |
Anika Therapeutics Inc |
Director |
– • – |
2020-09-03 |
4 |
A |
$0.00 |
$0 |
D/D |
9,310 |
9,310 |
0 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2020-08-05 |
4 |
AS |
$15.00 |
$150,000 |
D/D |
(10,000) |
60,458 |
0 |
% |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2020-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,488 |
70,458 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
|
• • – |
2019-10-07 |
4 |
B |
$15.00 |
$75,000 |
D/D |
5,000 |
5,000 |
0.01 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2019-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
7,262 |
61,970 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
